DNMT3A and neoplasm: Thus, the distinct immune landscapes of DNMT3A- and GMPS-driven tumors in liver versus pancreas can be rationalized by the different nutrient pathways that each enzyme controls and by organ-specific stromal contexts that dictate how those metabolites sculpt the tumor immune micro-environment.